{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T20:03:53Z","timestamp":1760385833822,"version":"3.33.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:00:00Z","timestamp":1518480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.14283\/jpad.2018.5","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T07:56:31Z","timestamp":1614326191000},"page":"202-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Correlation of CSF- and MRI-Biomarkers and Progression of Cognitive Decline in an Open Label MCI Trial"],"prefix":"10.1016","volume":"5","author":[{"given":"L.K.","family":"Joachim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Fr\u00f6lich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"R\u00fcther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kornhuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Heuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2018.5_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"Journal of Internal Medicine"},{"key":"10.14283\/jpad.2018.5_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to alzheimer's disease: Recommendations from the national institute on aging-alzheimer's association workgroups on diagnostic guidelines for alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers & Dementia"},{"key":"10.14283\/jpad.2018.5_bib3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/01.WNL.0000134664.80320.92","article-title":"Efficacy of donepezil in mild cognitive impairment-a randomized placebo-controlled trial","volume":"63","author":"Salloway","year":"2004","journal-title":"Neurology"},{"key":"10.14283\/jpad.2018.5_bib4","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin e and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.14283\/jpad.2018.5_bib5","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/01.wnl.0000344650.95823.03","article-title":"Donepezil treatment of patients with mci: A 48-week randomized, placebo-controlled trial","volume":"72","author":"Doody","year":"2009","journal-title":"Neurology"},{"key":"10.14283\/jpad.2018.5_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1474-4422(07)70109-6","article-title":"Effect of rivastigmine on delay to diagnosis of alzheimer's disease from mild cognitive impairment: The inddex study","volume":"6","author":"Feldman","year":"2007","journal-title":"Lancet neurology"},{"key":"10.14283\/jpad.2018.5_bib7","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/01.wnl.0000303815.69777.26","article-title":"Safety and efficacy of galantamine in subjects with mild cognitive impairment","volume":"70","author":"Winblad","year":"2008","journal-title":"Neurology"},{"key":"10.14283\/jpad.2018.5_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/153331750502000502","article-title":"Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: A double-blind placebo-controlled study","volume":"20","author":"Koontz","year":"2005","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.14283\/jpad.2018.5_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/gps.1711","article-title":"A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in aami)","volume":"22","author":"Ferris","year":"2007","journal-title":"International journal of geriatric psychiatry"},{"key":"10.14283\/jpad.2018.5_bib10","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1503\/cmaj.130451","article-title":"Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: A systematic review and meta-analysis","volume":"185","author":"Tricco","year":"2013","journal-title":"CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne"},{"key":"10.14283\/jpad.2018.5_bib11","first-page":"301","article-title":"Removal of subjects with a \u00abfalse positive\u201c diagnosis of mild cognitive impairment from the alzheimer's disease cooperative study (adcs) donepezil trial strengthens positive effects","volume":"4","author":"Edmonds","year":"2016","journal-title":"Journal of Prevention of Alzheimer's Disease"},{"key":"10.14283\/jpad.2018.5_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000210388","article-title":"Early and differential diagnosis of dementia and mild cognitive impairment design and cohort baseline characteristics of the german dementia competence network","volume":"27","author":"Kornhuber","year":"2009","journal-title":"Dementia and geriatric cognitive disorders"},{"key":"10.14283\/jpad.2018.5_bib13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12603-012-0062-8","article-title":"A combination of galantamine and memantine modifies cognitive function in subjects with amnestic mci","volume":"16","author":"Peters","year":"2012","journal-title":"The journal of nutrition, health & aging"},{"key":"10.14283\/jpad.2018.5_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in alzheimer's disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet neurology"},{"key":"10.14283\/jpad.2018.5_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2010.06.004","article-title":"Biomarkers in alzheimer's disease drug development","author":"Cummings","year":"2011","journal-title":"Alzheimer's & dementia: the journal of the Alzheimer's Association"},{"key":"10.14283\/jpad.2018.5_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-2011-111694","article-title":"Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in alzheimer's disease","volume":"29","author":"van Rossum","year":"2012","journal-title":"Journal of Alzheimer's disease: JAD"},{"key":"10.14283\/jpad.2018.5_bib17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm.2221","article-title":"Biomarkers in alzheimer's disease drug development","volume":"16","author":"Blennow","year":"2010","journal-title":"Nature medicine"},{"key":"10.14283\/jpad.2018.5_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","article-title":"Core candidate neurochemical and imaging biomarkers of alzheimer's disease","volume":"4","author":"Hampel","year":"2008","journal-title":"Alzheimers & Dementia"},{"key":"10.14283\/jpad.2018.5_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between csf biomarkers and incipient alzheimer's disease in patients with mild cognitive impairment: A follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet neurology"},{"key":"10.14283\/jpad.2018.5_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of beta-amyloid 1\u201342, but not of tau, are fully changed already 5 to 10 years before the onset of alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Archives of general psychiatry"},{"key":"10.14283\/jpad.2018.5_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pscychresns.2010.03.003","article-title":"Multicentre variability of mri-based medial temporal lobe volumetry in alzheimer's disease","volume":"182","author":"Teipel","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.14283\/jpad.2018.5_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neuropharm.2016.02.005","article-title":"Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal alzheimer's disease","volume":"108","author":"Teipel","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.14283\/jpad.2018.5_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1515\/cclm-2014-0414","article-title":"Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: A clinical cohort study","volume":"53","author":"Tondelli","year":"2015","journal-title":"Clinical chemistry and laboratory medicine: CCLM \/FESCC"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724005636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724005636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:14:15Z","timestamp":1737339255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724005636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2274580724005636"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2018.5","relation":{},"ISSN":["2274-5807"],"issn-type":[{"type":"print","value":"2274-5807"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of CSF- and MRI-Biomarkers and Progression of Cognitive Decline in an Open Label MCI Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2018.5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}